IPO - Diabetes device maker Beta Bionics files for $100M IPO
2025-01-07 16:44:46 ET
More on Renaissance Capital Greenwich Funds - Renaissance IPO ETF
- IPO: Favorable Capital Markets In 2025 Not Yet A Tailwind (Rating Downgrade)
- IPO Roundup: Cortigent, Diginex and more
- Medtech test developer Anbio files for $9M US IPO
- Seeking Alpha’s Quant Rating on Renaissance Capital Greenwich Funds - Renaissance IPO ETF
- Dividend scorecard for Renaissance Capital Greenwich Funds - Renaissance IPO ETF